Phio Pharmaceuticals Corp. (PHIO)
$0.92-6.12%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $11M
- Beta
- 0.80
- P/E (TTM)
- -0.74
- Short % float
- 0.78%
- Days to cover
- 1.0
- SI change
- -40.3%
- 1W
- -7.07%
- 1M
- -10.68%
- vs SPY 1W
- -7.49%
- vs SPY 1M
- -12.74%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PHIO?
- LOPJLB’s latest quantitative signal on Phio Pharmaceuticals Corp. (PHIO) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is PHIO in?
- Phio Pharmaceuticals Corp. (PHIO) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Phio Pharmaceuticals Corp. (PHIO) do?
- Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene …